SNOA

Sonoma Pharmaceuticals, Inc.

Boulder, Colorado • FY2026 Annual Report

NYSE H-1B Visa Sponsor

Revenue

N/A

Net Income

N/A

EBIT Margin

N/A

Diluted EPS

N/A

Free Cash Flow

$-4M

CEO Pay

$597,075

Amy Trombly

N/A

of Sonoma Pharmaceuticals, Inc.'s revenue comes from United States

Companies claim they must hire overseas workers because that's where their business is. The data says otherwise: Sonoma Pharmaceuticals, Inc. generates N/A of its $0B revenue from United States, yet continues to file H-1B petitions that displace American workers.

$597,075

Amy Trombly's total compensation in FY2026

Base salary $325,000 • Stock awards $37,732. The CEO's pay package is funded by the same company that claims it cannot find qualified American workers for its open positions.

Financial Snapshot — FY2026

Total Revenue

N/A

N/A year-over-year

Net Income

N/A

Operating Margin

N/A

Diluted EPS

N/A

Free Cash Flow

$-4M

Dividend / Share

N/A

Stock Buybacks

N/A

U.S.: 250 (N/A)

Where the Revenue Comes From — FY2026

Europe

$0B

N/A

United States

$0B

N/A

Asia

$0B

N/A

Latin America

$0B

N/A

Rest Of The World

$0B

N/A

Mexico

$0B

N/A

$0B

N/A

Revenue earned in the United States contradicts the claim that H-1B workers are needed because “that’s where the business is.” Source: SEC EDGAR 10-K, FY2026.

What We Pay the Executives Source: SEC DEF 14A via sec-api.io

CEO Total Compensation

$597,075

Amy Trombly

CEO Base Salary

$325,000

CEO Stock Awards

$37,732

Avg. Other NEO Total

$357,527

Executive	Title	Base Salary	Stock Awards	Total Comp
Amy Trombly🔍	Chief Executive Officer	$325,000	$37,732	$597,075
Bruce Thornton🔍	Executive Vice President and Chief Operating Officer	$260,800	$37,732	$532,369
Jerry Dvonch🔍	Chief Financial Officer	$240,000	$37,732	$357,527

SCT = Summary Compensation Table totals from SEC EDGAR DEF 14A proxy statement.

Board of Directors — Who Enables This

Director	Role	Age	Independent	Since	Tenure	Annual Pay
Amy Trombly🔍	Class I Director	None	No	N/A	N/A	N/A
Dr. Birnbaum🔍	Director	None	Yes	N/A	N/A	N/A
Jay Birnbaum🔍	Class II Director	None	Yes	N/A	N/A	N/A
Jerry McLaughlin🔍	Class III Director	None	Yes	N/A	N/A	N/A
Mr. Dvonch🔍	Director	None	Yes	N/A	N/A	N/A
Philippe Weigerstorfer🔍	Class I Director	None	Yes	N/A	N/A	N/A

Source: SEC EDGAR DEF 14A proxy statement via sec-api.io.

H-1B Visa Dependency Key Metric

Search all Sonoma Pharmaceuticals, Inc. H-1B Labor Condition Applications filed with the U.S. Dept. of Labor.

🔍 Search H-1B Records for Sonoma Pharmaceuticals, Inc.

Source: U.S. Dept. of Labor OFLC disclosure data. LCA filing does not guarantee a visa was issued.

Shareholder Value Assessment

PositiveCEO compensation of $0.6M is within range for company size.

Key Business Risks (from 10-K Item 1A)

Risk Factors Risks Related to Our Business We depend on third party distributors and intend to continue to license or collaborate with third parties in various potential markets, and events involving these strategic partners or any future collaboration could delay or prevent us from developing or commercializing products.
Our business strategy and our short- and long-term operating results depend in part on our ability to execute on existing strategic collaborations and to license or partner with new strategic partners.
We believe collaborations allow us to leverage our resources and technologies and to access markets that are compatible with our own core areas of expertise while avoiding the cost of establishing or maintaining a direct sales force in each market.
We may incur significant costs in the use of third parties and other resources to identify and assist in establishing relationships with potential collaborators.

♥

Help Support This Research

This analysis is produced independently — one person, 23 years of data work, living on $1,419/month Social Security. If these reports help you understand how H-1B visas affect American workers, a small donation makes a real difference.

♥ Donate via Square More Reports

Sonoma Pharmaceuticals, Inc.

of Sonoma Pharmaceuticals, Inc.'s revenue comes from United States

Amy Trombly's total compensation in FY2026

Help Support This Research

💬 Comments & Discussion